The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about many questions as hospitals and blood centers prepare to order the testing. We've put together a FAQ document to clarify what we know today. We will update the document as we get more information on existing questions and as new questions get asked, and will update the blog with the revised FAQ document.
Thanks for your support as we work to rapidly get this testing available to you. You can find the FAQ document here: CTS COVID-19 Questions and Answers
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
Creative Testing Solutions, the largest nonprofit blood testing organization in the U.S., today anno...
As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for sample...
On December 9, 2019, the new CTS Laboratory Information System successfully implemented in Phoe...
On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor anti...
On January 25, 2021, CTS implements the Ortho VIP viral marker testing platform. Conversion from the...